We are talking about the production of medicines based on messenger RNA (mRNA), as well as vector and protein vaccines.
The European Commission entered into an agreement with a number of pharmaceutical companies, including the US firm Pfizer, to reserve capacity for the annual production of 325 million vaccines in case of a humanitarian emergency. Reuters reported this on June 30.
According to the sources of the publication, we are talking about the future production of medicines based on messenger RNA (mRNA), as well as vector and protein vaccines.
It was clarified that the agreement is not related to existing agreements with the EU on the production of a coronavirus vaccine.
From the beginning of 2021, the European Commission concluded a series of contracts on behalf of the EU for the supply of more than 3 billion doses of coronavirus vaccines by 2024 with six Western manufacturers. The first was a contract with Pfizer.
It will be remembered that on May 5, the WHO announced the end of the COVID-19 pandemic. The coronavirus is no longer considered a global health emergency. However, the threat of the coronavirus remains.
On July 1, the quarantine and the state of emergency related to the coronavirus pandemic ends in Ukraine. According to the Minister of Health, Viktor Lyashko, the coronavirus disease has not disappeared, but is gradually becoming ordinary seasonal diseases.
Source: korrespondent
I’m Liza Grey, an experienced news writer and author at the Buna Times. I specialize in writing about economic issues, with a focus on uncovering stories that have a positive impact on society. With over seven years of experience in the news industry, I am highly knowledgeable about current events and the ways in which they affect our daily lives.